{
    "clinical_study": {
        "@rank": "139408", 
        "acronym": "IsletBOM 2", 
        "arm_group": [
            {
                "arm_group_label": "A: intraportal islet infusion", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will received islet  into the liver through the portal venous circulation (standard procedure)"
            }, 
            {
                "arm_group_label": "B: intra BM islet infusion", 
                "arm_group_type": "Experimental", 
                "description": "Patients will received an intra BM islet infusion at the level of the iliac crest. The direct intra BM administration will be performed following the same procedures that our institution utilizes for administration of cord-blood cells in patients with acute leukemia (Lancet Oncol. 2008;9:831). The procedure is easy and reproducible: a standard needle for BM aspiration is inserted in the iliac crest and cells are gently infused."
            }
        ], 
        "brief_summary": {
            "textblock": "The goal of this study is to evaluate safety and efficacy of bone marrow (BM) as site for\n      pancreatic islet transplantationin humans. Our hypothesis is that BM represents a better\n      site than liver (currently the location of choice for this procedure) thanks to its\n      potential capacity to favor islet engraftment. To address our hypothesis we propose herein a\n      randomized phase II trial to compare BM and liver as sites for islet transplantation in T1D\n      patients."
        }, 
        "brief_title": "Bone Marrow vs Liver as Site for Islet Transplantation", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 1 Diabetes", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study is a phase II, single center, open label, pilot study. We will recruit 12 patients\n      with T1D to be randomly (1:1) assigned to receive islet either into the liver through the\n      portal venous circulation (standard procedure; arm A, n=6) or directly into the BM at the\n      level of the iliac crest (arm B, n=6). Patients will be selected from those eligible for\n      islet Tx based on local practice and guidelines."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  diabetic patients eligible for pancreatic islet transplantation based on local\n             accepted practice and guidelines. This includes at least: a)clinical history\n             compatible with T1D with insulin-dependence for >5 years; b) undetectable stimulated\n             (arginine or MMTT) C-peptide levels (<0.3 ng/mL) in the 12 months before transplant\n             c)presence of severe hypoglycaemic events\n\n        Exclusion Criteria:\n\n          -  presence of hematologic disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01722682", 
            "org_study_id": "IsletBOM 2"
        }, 
        "intervention": {
            "arm_group_label": [
                "A: intraportal islet infusion", 
                "B: intra BM islet infusion"
            ], 
            "intervention_name": "Human pancreatic islet transplantation", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Diabetes", 
        "lastchanged_date": "November 5, 2012", 
        "link": {
            "url": "http://www.hsr.it/ricerca/divisioni-centri-istituti-e-programmi-di-ricerca/islet-trasplantation-program-itp/"
        }, 
        "location": {
            "contact": {
                "email": "paola.maffi@hsr.it", 
                "last_name": "Paola Maffi, MD", 
                "phone": "+390226432575"
            }, 
            "contact_backup": {
                "email": "lorenzo.piemonti@hsr.it", 
                "last_name": "Lorenzo Piemonti, MD", 
                "phone": "+390226432643"
            }, 
            "facility": {
                "address": {
                    "city": "Milan", 
                    "country": "Italy", 
                    "zip": "20132"
                }, 
                "name": "Ospedale San Raffaele"
            }, 
            "investigator": {
                "last_name": "Paola Maffi, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Bone Marrow vs Liver as Site for Islet Transplantation in Patients With Type 1 Diabetes: Pilot Study to Evaluate Efficacy", 
        "overall_contact": {
            "email": "piemonti.lorenzo@hsr.it", 
            "last_name": "Lorenzo Piemonti, MD", 
            "phone": "+390226432706"
        }, 
        "overall_contact_backup": {
            "email": "maffi.paola@hsr.it", 
            "last_name": "Paola Maffi, MD", 
            "phone": "+390226432575"
        }, 
        "overall_official": {
            "affiliation": "Ospedale San Raffaele", 
            "last_name": "Lorenzo Piemonti, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Centro Nazionale Trapianti (CNT)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "basal and -10 to 120 min time course of glucose, C-pep levels and insulin derived from the mixed meal tolerance test", 
            "measure": "Insulin secretion under stimulation", 
            "safety_issue": "No", 
            "time_frame": "month  12 post-Tx"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01722682"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ospedale San Raffaele", 
            "investigator_full_name": "Piemonti Lorenzo", 
            "investigator_title": "Head of Beta Cell Biology Unit, CO-Director Human Islet  Transplantation Program (ITP)", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence and severity of Adverse Events (AE) and Serious Adverse Events (SAE)", 
                "safety_issue": "Yes", 
                "time_frame": "throughout the study up to 1 year after first transplant"
            }, 
            {
                "description": "Change in average daily insulin requirements", 
                "measure": "Insulin requirement", 
                "safety_issue": "No", 
                "time_frame": "month 1, 3, 6, 9, 12 post- transplant"
            }, 
            {
                "description": "change in HbA1c, Transplant Estimated Function (TEF) and fasting C-peptide levels", 
                "measure": "Islet function", 
                "safety_issue": "No", 
                "time_frame": "month 1, 3, 6, 9, 12 post-Tx"
            }
        ], 
        "source": "Ospedale San Raffaele", 
        "sponsors": {
            "collaborator": {
                "agency": "Ministry of Health, Italy", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Ospedale San Raffaele", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}